310 likes | 496 Views
Results of the National Paediatric Bilateral Cochlear Implant Surgical Audit. Mr Stephen Broomfield ENT Locum Consultant University Hospitals Bristol Southampton, April 2013. Acknowledgements. Co-ordinating team: Professor G O’Donoghue John Murphy, Steve Emmett, Dominik Wild
E N D
Results of the National Paediatric Bilateral Cochlear Implant Surgical Audit Mr Stephen Broomfield ENT Locum Consultant University Hospitals Bristol Southampton, April 2013
Acknowledgements • Co-ordinating team: • Professor G O’Donoghue • John Murphy, Steve Emmett, Dominik Wild Nottingham University Hospitals NHS Trust • Working on behalf of: • The UK National Paediatric Cochlear Implant Surgical Audit Group
14 Contributing Centres Belfast Middlesbrough Birmingham Nottingham Bradford Oxford Bristol RNTNE Cambridge Southampton GOSH St George’s Manchester St Thomas’s
Acknowledgement • Funding for surgical audit: • Supported by a grant from the Healthcare Quality Improvement Partnership (HQIP) www.hqip.org.uk
Aims • To establish a large dataset of national paediatric cochlear implant procedures • To generate evidence for establishing future best surgical practice • Governance issues in early days of bilateral CI • Data for BCIG review of service • Data for NICE’s requirement to audit service
Aims • To address the real concern about surgery/ anaesthesia of parents considering CI for their child • Although risk of complications low following CI, potential might be increased with bilateral simultaneous CI e.g. blood loss, vestibular impairment
Methods • Prospective multi-centre audit • All CIs in children (birth to 18 yrs) included • Surgeon completed voluntary questionnaire • Collection Jan 2010 to Dec 2011 • Data collected including: • Demographics • Aetiology • Co-morbidity • Electrophysiology/ imaging • Complications • Length of stay
Results - Demographics • 961 CI recipients (1397 implants) • 436 bilateral simultaneous • 394 bilateral sequential • 131 unilateral • Male:Female 474:462 (data missing n=25)
Results – Change in Surgery • 8 cases (1.8%) of planned bilateral CI became unilateral: • Mucosal bleeding (n=3) • Cochlear obliteration (n=2) • Anaesthetic/medical concerns intra-op (n=2) • Anatomical difficulties (n=1)
Results - Age • Age at Implantation (n=916) Years:Months • Mean age 6:1 (median 4:9, range 4m to 18y) • For congenitally deaf having bilateral CI (n=345):Mean age 3:1 (median 2:2, range 4m to 17:8) • For sequential CI (n= 383):Mean age 8:8 (median 8:2, range 7y to 18y)
Results - Aetiology • Congenital n=799 (83%) • Majority unknown aetiology n=639 (80%) • Connexin 26 n=41 (4.2%) • Usher n=14 (1.8%) • Waardenburg n=12 (1.5%) • Pendred n=10 (1.3%) • Acquired n=141 (14.7%) • Meningitis n=55 (39.0%) • CMV n=35 (24.8%) • Not specified n=21 (2.2%)
Results – Pre-op Imaging • Recorded in 925 cases (96.3%) • Both MRI and CT 511 (55.2%) • MRI alone 280 (30.2%) • CT alone 134 (14.5%)
Results - Duration of Surgery Times in hours:minutes. Entering anaesthetic room to leaving theatre
Results - Duration of Surgery Data for Bilateral Simultaneous CI (n=284)
Results - Duration of Surgery Data for Bilateral Simultaneous CI (n=284)
Results - Duration of Surgery • Duration of surgery for cases of bilateral simultaneous CI: • With trainee (n= 142) 4:36 • No trainee (n=136) 4:26 Extent of involvement/ complexity of cases not recorded
Results – Intra-operative Tests • Documented in 910 cases (95%) • Telemetry to measure electrically evoked cortical action potential (ECAP) from auditory nerve in626 (69%) • CI integrity test without full ECAP in 55 (6%) • Stapedial reflexes in 129 (14%)
Results – Post-op Imaging • Documented in 854 (89%) cases: • Post op X-ray n=603 (71%) • Intra-op X-ray n=111 (13%) • Both intra- and post-op n=75 (9%) • No imaging n=65 (8%)
Results – Length of Stay n=795. Maximum length of stay was 9 days
Complications Major Complication An adverse event occurring during or after surgery (short term) that necessitated a further major surgical intervention, admission to ITU, exposure to invasive intervention or a permanent disability such as persistent facial weakness Minor Complication An adverse event managed (short term) by medical measures or by a minor surgical procedure (e.g. aspiration of a haematoma) Bhatia K, et al. OtolNeurotol2004;25:730-739. Hansen S, et al.ActaOto-laryngologcia2010;130:540-549.
Complications • Immediate • intra-operative or first week following surgery • Delayed • occurring after one week, within the period of the audit Immediate and delayed major complications recordedOnly immediate minor complications recorded
Immediate Major Complications • CSF leak requiring lumbar drain 2 (0.2%) • Bleeding requiring transfusion 1 (0.1%) • Return to theatre to reposition 1 (0.1%) • No permanent facial palsy, no deaths
Delayed Major Complications • Device failure 6 (0.6%) • Wound infection with explantation 2 (0.2%) • Meningitis 1 (0.1%) • Wound infection drained in theatre 1 (0.1%) • Theatre for air collection over implant 1 (0.1%) • Note range of follow up 0 to 24m, mean 12.5m • Overall major complication rate 1.6% (0.9% if device failures excluded)
Immediate Minor Complications • Intra-op • CSF Leak 4 (0.4%) • Tip rollover – device changed 2 (0.2%) • Device not working – changed 1 (0.1%) • Device repositioned 1 (0.1%) • Post-op • Imbalance – prolonged stay 12 (1.3%) • Swelling – conservative mx 11 (1.1%) • Bleeding/ haematoma - cons mx 10 (1.0%) • Wound infection – abx 7 (0.7%) • Tip rollover – no revision 4 (0.4%) • Facial weakness – partial 2 (0.2%)
Immediate Minor Complications • 62 reported overall (6.5%) • 12 cases of imbalance • 4 bilateral simultaneous, 5 sequential, 3 unilateral • Most (n=10) required one additional night • Maximum (n=2) required 3 nights • 2 cases of partial (House Brackmann grade 3) facial weakness • Both resolved
Results - Complications • Patients presenting with complications spread evenly across centres • No differences detectable between bilateral simultaneous, sequential, unilateral
Conclusion • Collaboration across the UK has allowed for one of the largest reported series to date • All UK centres employ a similar approach: • Experienced teams • Modern surgical practices • Centres with access to paediatric, anaesthetic and ICU support (RCS Guidelines) • Adherence to immunisation protocols • Intra-operative precautions • High vigilance for complications
Conclusion – Areas for Improvement • Longer follow up • International consensus on reporting of complications • Improved reporting of all audit data points
Conclusion • Overall major complication rate 1.6% (0.9% excluding device failures) • Comparable to other large series • No permanent facial palsies, no deaths • No evidence for increased complications following bilateral simultaneous compared to sequential or unilateral CI
Conclusion This study provides evidence that bilateral paediatric cochlear implantation, whether simultaneous or sequential, is a safe procedure in cochlear implant centres in the UK, thus endorsing its role as a major therapeutic intervention in childhood deafness.